RecruitingPhase 4

The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion

United States140 participantsStarted 2022-02-01

Plain-language summary

The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * degenerative lumbar disease * age of 18-75 * undergoing open primary one- to three-level lumbar fusion Exclusion Criteria: * currently use a sleep aid nightly * diagnosed with insomnia or sleep apnea * history of delirium with opiates or zolpidem * allergic to opiates or zolpidem * had previous lumbar spine surgery * undergoing minimally invasive lumbar fusion, * undergoing lumbar fusion for fracture, infection, tumor, or an inflammatory spondyloarthropathy

What they're measuring

Visual analog scale (VAS)

Timeframe: Postoperative day five

Trial details

NCT IDNCT05746143

SponsorUniversity of Southern California

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-01-31

Contact for this trial

Pui Yan, MS

323-442-6984 puiyan@med.usc.edu

View on ClinicalTrials.gov More Spine Fusion trials